FDA NDC Directory · JSON-LD · Markdown

Cefdinir

NDC 65862-219 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA065473
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCEFDINIR (250 mg/5mL)
Marketing started20071214
Package count2

External sources

Source: openFDA. Public-domain (CC0).